‘Exciting’ clinical results offer hope for new class of MS therapies
PositiveWorld Affairs

Exciting early results from a clinical trial in Cambridge indicate that a common diabetes drug, when combined with an antihistamine, may help repair nerve damage associated with multiple sclerosis. Although patients did not notice significant benefits after six months, improvements in nerve function were observed, raising hopes for future therapies. This research is important as it could lead to new treatment options for those suffering from MS, potentially improving their quality of life.
— Curated by the World Pulse Now AI Editorial System